Sierra Oncology, Inc. 4
4 · Sierra Oncology, Inc. · Filed Mar 8, 2017
Insider Transaction Report
Form 4
Glover Nicholas
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2017-03-06+195,000→ 195,000 totalExercise: $1.45Exp: 2027-03-06→ Common Stock (195,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the total shares on January 1, 2018, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on January 1, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.